What is the difference between intrinsic and idiosyncratic hepatotoxicity?

Intrinsic hepatotoxicity is dose-dependent and largely predictable, as with acetaminophen overdose. Idiosyncratic hepatotoxicity is mostly independent of dose, depends on host factors, and is rare and difficult to anticipate for any given drug.

Why is the liver so often the organ injured by drugs?

The liver receives ingested chemicals through the portal circulation and is the main site of drug metabolism, so it is exposed both to high drug concentrations and to the reactive metabolites it produces.

Hepatotoxicity and Drug-Induced Liver Injury

Hepatotoxicity is liver injury caused by drugs, herbal products, or other chemicals. Because the liver is the body's principal site of drug metabolism, it is especially exposed to reactive metabolites, and drug-induced liver injury (DILI) is both a leading reason for drug withdrawal from the market and an important cause of acute liver failure.

Definition

Hepatotoxicity, or drug-induced liver injury, is damage to the liver — ranging from asymptomatic enzyme elevations to hepatocellular necrosis and acute liver failure — attributable to exposure to a drug, herbal or dietary supplement, or other xenobiotic.

Scope

This topic covers the patterns of chemically induced liver injury, the distinction between intrinsic (dose-dependent, predictable) and idiosyncratic (host-dependent, largely unpredictable) hepatotoxicity, the principal mechanisms of hepatocellular injury, and the way DILI is recognised and classified. It is a reference and educational entry, not a guide to diagnosis or management.

Core questions

What distinguishes intrinsic from idiosyncratic drug-induced liver injury?
Why is the liver particularly vulnerable to chemical injury?
How are hepatocellular, cholestatic, and mixed patterns of injury defined?
How is a liver injury attributed to a specific drug?

Key concepts

Intrinsic (dose-dependent) hepatotoxicity
Idiosyncratic hepatotoxicity
Hepatocellular vs cholestatic vs mixed injury
Reactive metabolites and glutathione depletion
R-value pattern classification
Hy's Law

Key theories

Reactive metabolite hypothesis: Many hepatotoxins are not themselves toxic but are bioactivated by hepatic enzymes (notably cytochrome P450) into reactive metabolites that bind cellular proteins, deplete glutathione, and trigger oxidative stress and cell death; acetaminophen is the archetypal example of dose-dependent injury through this route.

Mechanisms

The liver receives blood from the portal circulation and is rich in drug-metabolising enzymes, so it is exposed to high concentrations of ingested chemicals and of any reactive metabolites it generates. Intrinsic hepatotoxins, such as acetaminophen in overdose, cause predictable, dose-related injury by generating reactive metabolites that overwhelm protective glutathione and damage hepatocytes. Idiosyncratic injury is largely independent of dose and depends on host factors, including immune and adaptive responses, making it rare for any given drug but collectively important; proposed mechanisms include haptenation of proteins by reactive metabolites, mitochondrial injury, and adaptive immune activation (Lee, 2003; Tujios & Fontana, 2011).

Clinical relevance

Drug-induced liver injury is a major concern in drug development and pharmacovigilance and a recognised cause of acute liver failure. The concept of Hy's Law — that hepatocellular injury accompanied by jaundice signals a serious prognosis — illustrates how patterns of liver-test abnormality are interpreted as safety signals. This entry describes how hepatotoxicity is understood and classified and is not a basis for individual diagnosis or treatment decisions.

Epidemiology

In a large prospective United States registry, antimicrobials were the most common class of agents implicated in idiosyncratic drug-induced liver injury, and herbal and dietary supplements accounted for a meaningful share of cases; a substantial minority of patients had persistent or severe injury (Chalasani et al., 2008). Acetaminophen toxicity is, separately, a leading identifiable cause of acute liver failure in many countries.

History

Systematic understanding of drug hepatotoxicity owes much to Hyman Zimmerman, whose observations on jaundice accompanying hepatocellular injury became codified as Hy's Law. Prospective registries such as the United States Drug-Induced Liver Injury Network later characterised the causes and outcomes of idiosyncratic injury in contemporary practice (Chalasani et al., 2008).

Debates

How can idiosyncratic drug-induced liver injury be predicted?: Because idiosyncratic injury is rare and host-dependent, it is difficult to detect in pre-marketing trials; the relative contributions of metabolic, mitochondrial, and immune mechanisms, and the value of genetic risk markers, remain active questions.

Key figures

William Lee
Robert Fontana
Naga Chalasani
Hyman Zimmerman

Seminal works

lee-2003
chalasani-2008

Frequently asked questions

What is the difference between intrinsic and idiosyncratic hepatotoxicity?: Intrinsic hepatotoxicity is dose-dependent and largely predictable, as with acetaminophen overdose. Idiosyncratic hepatotoxicity is mostly independent of dose, depends on host factors, and is rare and difficult to anticipate for any given drug.
Why is the liver so often the organ injured by drugs?: The liver receives ingested chemicals through the portal circulation and is the main site of drug metabolism, so it is exposed both to high drug concentrations and to the reactive metabolites it produces.